AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 203 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $940,000 | -35.0% | 29,000 | 0.0% | 0.21% | -32.1% |
| Q2 2019 | $1,447,000 | -26.0% | 29,000 | 0.0% | 0.30% | -29.6% |
| Q1 2019 | $1,956,000 | +46.3% | 29,000 | 0.0% | 0.43% | +30.0% |
| Q4 2018 | $1,337,000 | -40.2% | 29,000 | 0.0% | 0.33% | -27.3% |
| Q3 2018 | $2,236,000 | -8.5% | 29,000 | 0.0% | 0.46% | -14.7% |
| Q2 2018 | $2,443,000 | +3.0% | 29,000 | 0.0% | 0.54% | +1.9% |
| Q1 2018 | $2,372,000 | +43.1% | 29,000 | 0.0% | 0.53% | +43.6% |
| Q4 2017 | $1,658,000 | -14.4% | 29,000 | 0.0% | 0.37% | -19.3% |
| Q3 2017 | $1,936,000 | +29.8% | 29,000 | 0.0% | 0.46% | +21.0% |
| Q2 2017 | $1,492,000 | – | 29,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |